HQY is a Zacks Rank #2 (Buy) stock, with a Growth Style Score of A and VGM Score of B. Earnings are expected to grow 37.3% ...

HealthEquity (HQY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Atria Investments Inc cut its stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 19.5% in the 3rd quarter, ...

Fintel reports that on November 15, 2024, Goldman Sachs initiated coverage of HealthEquity (NasdaqGS:HQY) with a Neutral ...

This award recognizes Padia’s creative vision to develop the HealthEquity Immersion Experience — a project that showcases HealthEquity’s deep understanding of the client and member benefits journey ...

David Roman, an analyst from Goldman Sachs, has initiated a new Hold rating on Healthequity (HQY). David Roman has given his Hold rating due to ...

BTIG raised the firm’s price target on HealthEquity (HQY) to $130 from $110 and keeps a Buy rating on the shares. The firm is citing improving policy fundamentals, better visibility into demand ...

So far this year, the Zacks Rank #3 (Hold) stock has gained 43% against 5.6% decline of the industry.The S&P 500 has ...

Goldman Sachs initiates buy rating on Teladoc Health with $14 price target, while assigning neutral ratings on Doximity and HealthEquity. Read more here.

HealthEquity, Inc. HQY has been gaining from its business model and strategy. The optimism, led by a solid second-quarter fiscal 2025 performance and strength in Health Savings Accounts (“HSA ...